These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8713701)

  • 1. Increased urinary endothelin excretion in patients with liver cirrhosis.
    Kitano M; Uemasu J; Kawasaki H
    J Gastroenterol Hepatol; 1996 Apr; 11(4):347-52. PubMed ID: 8713701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal kinin and kallikrein excretion in cirrhotic patients.
    Yuki N; Kubo M; Noro Y; Hayashi N; Fusamoto H; Ito A; Masuzawa M; Kamada T
    Scand J Gastroenterol; 1991 Oct; 26(10):1075-81. PubMed ID: 1947775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis.
    Uchihara M; Izumi N; Sato C; Marumo F
    Hepatology; 1992 Jul; 16(1):95-9. PubMed ID: 1535610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does endothelin-1 play a role in the renal function of cirrhotic patients?
    Bruno CM; D'Amico R; Ierna D; Neri S
    Panminerva Med; 1998 Sep; 40(3):196-8. PubMed ID: 9785916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the endothelin system on water and sodium excretion in patients with liver cirrhosis.
    Hocher B; Brause M; Mendes U; Berger D; Bühler H; Gross P
    Nephrol Dial Transplant; 1999 May; 14(5):1133-8. PubMed ID: 10344351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in plasma endothelin-1 and Big endothelin-1 induced by transjugular intrahepatic portosystemic shunts in patients with cirrhosis and refractory ascites.
    Martinet JP; Legault L; Cernacek P; Roy L; Dufresne MP; Spahr L; Fenyves D; Pomier-Layrargues G
    J Hepatol; 1996 Nov; 25(5):700-6. PubMed ID: 8938548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily profile of plasma endothelin-1 and -3 in pre-ascitic cirrhosis: relationships with the arterial pressure and renal function.
    Trevisani F; Colantoni A; Gerbes AL; Gülberg V; Sica G; Caraceni P; De Notariis S; Morselli-Labate AM; Ligabue A; Gasbarrini G; Bernardi M
    J Hepatol; 1997 Apr; 26(4):808-15. PubMed ID: 9126793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma endothelin-1 concentrations are elevated in acute hepatitis and liver cirrhosis but not in chronic hepatitis.
    Uchida Y; Watanabe M
    Gastroenterol Jpn; 1993 Oct; 28(5):666-72. PubMed ID: 8224617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regulation of natriuresis in diabetic nephropathy].
    Późniak J
    Ann Acad Med Stetin; 2000; 46():241-52. PubMed ID: 11712308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased endothelin excretion in rats with renal failure induced by partial nephrectomy.
    Brooks DP; Contino LC; Storer B; Ohlstein EH
    Br J Pharmacol; 1991 Dec; 104(4):987-9. PubMed ID: 1810606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma endothelin levels in patients with cirrhosis and their relationships to the severity of cirrhosis and renal function.
    Tsai YT; Lin HC; Yang MC; Lee FY; Hou MC; Chen LS; Lee SD
    J Hepatol; 1995 Dec; 23(6):681-8. PubMed ID: 8750167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary kallikrein excretion in chronic liver disease and effect of indomethacin.
    Kawasaki H; Murawaki Y; Hirayama C
    Am J Gastroenterol; 1986 Jan; 81(1):67-70. PubMed ID: 3510529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kallikrein-kininogen-kinin system in patients with liver disease and ascites.
    Solomon R; Azar P; Trebbin W; Weinberg MS
    Nephron; 1988; 50(1):39-44. PubMed ID: 3173599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal kallikrein excretion in alcoholic cirrhosis. Relationship to other vasoactive systems.
    Zipser RD; Kerlin P; Hoefs JC; Zia P; Barg A
    Am J Gastroenterol; 1981 Mar; 75(3):183-7. PubMed ID: 7015845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infusion of radiocontrast agents induces exaggerated release of urinary endothelin in patients with impaired renal function.
    Fujisaki K; Kubo M; Masuda K; Tokumoto M; Hirakawa M; Ikeda H; Matsui R; Matsuo D; Fukuda K; Kanai H; Hirakata H; Iida M
    Clin Exp Nephrol; 2003 Dec; 7(4):279-83. PubMed ID: 14712357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of plasma endothelin-1 in patients with chronic liver disease.
    Matsumoto H; Uemasu J; Kitano M; Kawasaki H
    Dig Dis Sci; 1994 Dec; 39(12):2665-70. PubMed ID: 7995194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of renal kallikrein in the derangement of sodium and water excretion in cirrhotic patients.
    Hattori K; Hasumura Y; Takeuchi J
    Scand J Gastroenterol; 1984 Sep; 19(6):844-8. PubMed ID: 6393317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased urinary excretion of aquaporin 2 in patients with liver cirrhosis.
    Ivarsen P; Frøkiaer J; Aagaard NK; Hansen EF; Bendtsen F; Nielsen S; Vilstrup H
    Gut; 2003 Aug; 52(8):1194-9. PubMed ID: 12865281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma endothelin-1 and -3 in cirrhosis: relationship with systemic hemodynamics, renal function and neurohumoral systems.
    Bernardi M; Gulberg V; Colantoni A; Trevisani F; Gasbarrini A; Gerbes AL
    J Hepatol; 1996 Feb; 24(2):161-8. PubMed ID: 8907569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portal and systemic hemodynamics and humoral factors in cirrhosis with and without ascites.
    Hayes PC; Cumming AD; Craig KJ; Watson M; Bouchier IA
    Am J Gastroenterol; 1992 Oct; 87(10):1433-8. PubMed ID: 1415100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.